Evidence map›Paper›PMID 17537914›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.

Erin J Adams, Z Sean Juo, Rayna Takaki Venook, Martin J Boulanger, Hisashi Arase, Lewis L Lanier, K Christopher Garcia

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Memory and Memory-Like NK Cell Responses to Microbial Pathogens.Frontiers in cellular and infection microbiology · 2020
    Review
  12. Review
  13. Review
  14. Review
  15. Natural Killer Cells in Antifungal Immunity.Frontiers in immunology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Erin J AdamsDepartments of Molecular and Cellular Physiology and Structural Biology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Z Sean Juo
Rayna Takaki Venook
Martin J Boulanger
Hisashi Arase
Lewis L Lanier
K Christopher Garcia
University of California, San Francisco · USCancer Research Institute · USHoward Hughes Medical Institute · USStanford University · US

Funding

NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
NIAID NIH HHS AI 068129NIAID NIH HHS AI 10655 04NIAID NIH HHS R01 AI068129
6 · The paper itself

Abstract

Natural killer (NK) cells express activating and inhibitory receptors that, in concert, survey cells for proper expression of cell surface major histocompatibility complex (MHC) class I molecules. The mouse cytomegalovirus encodes an MHC-like protein, m157, which is the only known viral antigen to date capable of engaging both activating (Ly49H) and inhibitory (Ly49I) NK cell receptors. We have determined the 3D structure of m157 and studied its biochemical and cellular interactions with the Ly49H and Ly49I receptors. m157 has a characteristic MHC-fold, yet possesses several unique structural features not found in other MHC class I-like molecules. m157 does not bind peptides or other small ligands, nor does it associate with beta(2)-microglobulin. Instead, m157 engages in extensive intra- and intermolecular interactions within and between its domains to generate a compact minimal MHC-like molecule. m157's binding affinity for Ly49I (K(d) approximately 0.2 microM) is significantly higher than that of classical inhibitory Ly49-MHC interactions. Analysis of viral escape mutations on m157 that render it resistant to NK killing reveals that it is likely to be recognized by Ly49H in a binding mode that differs from Ly49/MHC-I. In addition, Ly49H+ NK cells can efficiently lyse RMA cells expressing m157, despite the presence of native MHC class I. Collectively, our results show that m157 represents a structurally divergent form of MHC class I-like proteins that directly engage Ly49 receptors with appreciable affinity in a noncanonical fashion.

Indexed as

AnimalsAntigens, LyBaculoviridaeBinding SitesCell Line, TumorCrystallography, X-RayDisulfidesHistocompatibility Antigens Class IHydrogen BondingKiller Cells, NaturalLectins, C-TypeLigandsLymphoma, T-CellMiceModels, MolecularMuromegalovirusAntigens, LyDisulfidesHistocompatibility Antigens Class IKlra8 protein, mouseLectins, C-TypeLigandsNK Cell Lectin-Like Receptor Subfamily AReceptors, ImmunologicReceptors, NK Cell Lectin-Like

Identifiers

PMID17537914
PMCPMC1891256
OpenAlexW2038034255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.